title: Clinical significance of 2 h plasma concentrations of first-line anti-tuberculosis drugs: a prospective observational study--authors' response.
authors.affiliation: International Reference Laboratory of Mycobacteriology, Statens Serum Institut, 5 Artillerivej, 2300 Copenhagen, Denmark jpl@ssi.dk.
authors.forename: Julie B
authors.initials: JB
authors.lastname: Prahl
authors.affiliation: Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.
authors.forename: Isik S
authors.initials: IS
authors.lastname: Johansen
authors.affiliation: Department of Biochemistry, Immunology and Genetics, Statens Serum Institut, 5 Artillerivej, 2300 Copenhagen, Denmark.
authors.forename: Arieh S
authors.initials: AS
authors.lastname: Cohen
authors.affiliation: Department of Clinical Microbiology, Copenhagen University Hospital Hvidovre, Kettegård Alle 30, 2650 Hvidovre, Denmark.
authors.forename: Niels
authors.initials: N
authors.lastname: Frimodt-Møller
authors.affiliation: Department of Infectious Diseases, Copenhagen University Hospital Rigshospitalet, 9 Blegdamsvej, 2100 Copenhagen Ø, Denmark.
authors.forename: Åse B
authors.initials: ÅB
authors.lastname: Andersen
mesh_terms: D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D008297:Male; D014376:Tuberculosis / Q000188:drug therapy*; D064887:Observational Studies as Topic
chemical_list: D000995:Antitubercular Agents
keywords: anti-tuberculosis drugs; therapeutic drug monitoring; tuberculosis